A new study has shown that overall and cause-specific mortality rates in individuals in the U.S. with low-risk differentiated thyroid cancer (DTC) are low. The study is published in the peer-reviewed journal Thyroid®, the official journal of the American Thyroid Association® (ATA®). Click here to read the article now.
Credit: Mary Ann Liebert, Inc., publishers
A new study has shown that overall and cause-specific mortality rates in individuals in the U.S. with low-risk differentiated thyroid cancer (DTC) are low. The study is published in the peer-reviewed journal Thyroid®, the official journal of the American Thyroid Association® (ATA®). Click here to read the article now.
Cari Kitahara, PhD, from the National Cancer Institute, National Institutes of Health, and coauthors identified 51,854 individuals diagnosed with first primary DTC at low risk of recurrence and compared observed mortality rates in DTC patients with expected rates in the matched U.S. general population. Thyroid cancer accounted for only 4.3% of deaths. The most common causes of death were malignancies (other than thyroid cancer) and cardiovascular disease.
“In brief, we observed that these patients experienced lower rates of mortality overall and from most other causes compared with the general population, consistent with previous studies,” stated the investigators. “Our study is unique, in that it was restricted to survivors of low-risk DTC and included all ages at diagnosis, a longer duration of follow-up compared with previous studies, and a comprehensive investigation of specific causes of death.”
About the Journal
Thyroid®, the official journal of the American Thyroid Association®, (ATA®) is an authoritative peer-reviewed journal published monthly online with open access options and in print. Led by Editor-in-Chief Anna M. Sawka, MD, PhD, University of Toronto, the Journal publishes original articles and timely reviews that reflect the rapidly advancing changes in our understanding of thyroid physiology and pathology, from the molecular biology of the cell to clinical management of thyroid disorders. Complete tables of content and a sample issue may be viewed on the Thyroid website. The complete Thyroid Journal Program includes the highly valued abstract and commentary publication Clinical Thyroidology®, led by Editor-in-Chief Trevor Angell, MD and published monthly, and the groundbreaking video journal companion VideoEndocrinology, led by Editor Catherine F. Sinclair, MD, FRACS. Complete tables of content and sample issues may be viewed on the Thyroid website.
About the American Thyroid Association®
The American Thyroid Association® (ATA) is dedicated to transforming thyroid care through clinical excellence, education, scientific discovery and advocacy in a collaborative and diverse community. ATA® is an international professional medical society with over 1,800 members from 43 countries around the world. The ATA® promotes thyroid awareness and information through Clinical Thyroidology® for the Public, a resource that summarizes research for patients and families, and extensive, authoritative resources on thyroid disease and thyroid cancer in both English and Spanish. The ATA® website www.thyroid.org serves as a bona fide clinical resource for patients and the public who look for reliable thyroid-related information.
About the Publisher
Mary Ann Liebert, Inc. is a global media company dedicated to creating, curating, and delivering impactful peer-reviewed research and authoritative content services to advance the fields of biotechnology and the life sciences, specialized clinical medicine, and public health and policy. For complete information, please visit the Mary Ann Liebert, Inc. website.
Journal
Thyroid
DOI
10.1089/thy.2023.0449
Method of Research
Observational study
Subject of Research
People
Article Title
All-Cause and Cause-Specific Mortality Among Low-Risk Differentiated Thyroid Cancer Survivors in the United States
Article Publication Date
21-Mar-2024